Boehringer Ingelheim Pharma v OHMI – Nepentes Pharma (Momarid): ECFI 2 Dec 2014

ECJ Judgment – Community trade mark – Opposition proceedings – Application for the Community word mark Momarid – Earlier Community word mark LONARID – Relative ground for refusal – Likelihood of confusion – Article 8(1)(b) of Regulation (EC) No 207/2009 – Relevant public – Obligation to state reasons – Article 75 of Regulation No 207/2009

S. Papasavvas, P
T-75/13, [2014] EUECJ T-75/13, ECLI:EU:T:2014:1017
Bailii
Regulation (EC) No 207/2009 75

European, Intellectual Property

Updated: 24 December 2021; Ref: scu.539574